(Q35040861)

6 August 2017

1 reference

title

Antigen-based immune modulation: DNA vectors and beyond (English)

1 reference

6 August 2017

3

Matthias von Herrath

1 reference

6 August 2017

Adrian Bot

1

1 reference

6 August 2017

William J Phillips

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Expert Opinion on Biological Therapy

6 August 2017

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

929-942

1 reference

Dendritic cells in autoimmune diseases

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Etanercept in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Genetic and pathogenic basis of autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

T-cell education in autoimmune diabetes: teachers and students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

DNA immunization to prevent autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Proinflammatory and immunoregulatory functions of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

T-cell anergy and peripheral T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Activation of naive, memory and effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

The role of CpG dinucleotides in DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

DNA vaccines for the treatment of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Identification of an oligodeoxynucleotide sequence motif that specifically inhibits phosphorylation by protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

21 January 2018

HLA and type I diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.929

21 January 2018

Identifiers

DOI

10.1517/14712598.2.8.929

1 reference

6 August 2017

1 reference